Table 3.
Priming/booster group | Mean ± SD cytokine concn (pg/ml) |
|||
---|---|---|---|---|
Spleen |
Peyer's patches |
|||
IFN-γ | IL-4 | IFN-γ | IL-4 | |
Nonvaccinated | 302.2 ± 18.7a | 165.6 ± 25.6a | 83.7 ± 14.9a | 31.4 ± 13.9a |
GK-1/GK-1 | 493.4 ± 53.4b | 195.9 ± 31.5a | 168.9 ± 18.3b | 78.9 ± 12.6a |
BLS-GK-1/GK-1 | 690.6 ± 45.9c | 289.7 ± 21.5b | 156.2 ± 10.9b | 100.3 ± 17.7a |
BLS + GK-1/GK-1 | 1,079.0 ± 172.1d | 417.5 ± 51.3c | 216.3 ± 13.2b | 129.1 ± 15.2a,b |
Groups of 9 mice were orally primed with GK-1, BLS-GK-1, or BLS plus GK-1 and boosted with GK-1. At 15 days after the third immunization, lymphocytes were recovered from PP, MLN, and spleen cells, and the lymphocytes from groups of three mice were pooled and placed in 12-well cluster plates. The plates were incubated at 37°C 5% in a CO2 humidified atmosphere supplemented with RPMI 1640 in the presence or absence of BLS or GK-1, according to the immunization protocol. Twelve hours before supernatant collection, ConA was added to nonimmunized and GK-1-immunized cells. Supernatants were collected and stored at −80°C until they used to determine the cytokine levels. Data represent the cytokine concentration secreted by tissue cells. Different letters indicate significant differences at P < 0.05 (Tukey-Kramer multiple-comparisons test).